MobiHealth News December 4, 2023
The gastrointestinal surgery-focused company will use the funds to advance its endoluminal robotics technology for minimally invasive procedures.
EndoQuest, an endoluminal robotics technology company, announced it closed a $42 million C-1 preferred financing round.
Existing investors CE Ventures Limited and McNair Interests Ltd. participated in the round, as did new investor Puma Venture Capital LLC.
WHAT IT DOES
The Houston-based company developed a flexible robotics surgery system to perform minimally invasive procedures in upper and lower gastrointestinal and other endoluminal areas. The platform allows for endoluminal and single-incision surgery through the body’s natural orifices or via a transumbilical incision.
EndoQuest plans to use the funds for growth, which includes scaling its commercialization efforts, achieving regulatory milestones and furthering...
Today's Sponsors
Today's Sponsor